{
    "nctId": "NCT00393341",
    "briefTitle": "Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer",
    "officialTitle": "Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Stage IV, Breast Cancer Stage I, Breast Cancer Stage II",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 68,
    "primaryOutcomeMeasure": "To quantitate endothelial progenitor cells (EPCs) in early and advanced breast cancer patients. Different type of EPCs will be isolated from the blood and quantitated.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of metastatic breast cancer(stage IV), or women with a history of Stage I or II breast cancer disease who are currently disease free Women greater than or equal to 18 years of age Ability to understand and the willingness to sign an informed consent\n\nExclusion Criteria:\n\n* Chemotherapy, radiation, or surgery within the past 4 weeks.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}